Free Trial

Zimmer Biomet (ZBH) Short Interest Ratio & Short Volume

Zimmer Biomet logo
$93.67 +0.17 (+0.18%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$94.44 +0.77 (+0.82%)
As of 05:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Short Interest Data

Zimmer Biomet (ZBH) has a short interest of 6.42 million shares, representing 3.25% of the float (the number of shares available for trading by the public). This marks a 16.52% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 1.80 million shares to cover all short positions.

Current Short Interest
6,420,000 shares
Previous Short Interest
5,510,000 shares
Change Vs. Previous Month
+16.52%
Dollar Volume Sold Short
$585.70 million
Short Interest Ratio
2.8 Days to Cover
Last Record Date
June 15, 2025
Outstanding Shares
197,850,000 shares
Float Size
197,580,000 shares
Short Percent of Float
3.25%
Today's Trading Volume
927,032 shares
Average Trading Volume
1,804,154 shares
Today's Volume Vs. Average
51%
Short Selling Zimmer Biomet?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Zimmer Biomet and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ZBH Short Interest Over Time

ZBH Days to Cover Over Time

ZBH Percentage of Float Shorted Over Time

Zimmer Biomet Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/20256,420,000 shares $585.70 million +16.5%3.3%2.8 $91.23
5/31/20255,510,000 shares $507.58 million -7.4%2.8%2.4 $92.12
5/15/20255,950,000 shares $575.25 million -5.1%3.0%2.6 $96.68
4/30/20256,270,000 shares $646.19 million -0.2%3.2%2.8 $103.06
4/15/20256,280,000 shares $610.58 million -12.8%3.2%3.1 $97.23
3/31/20257,200,000 shares $815.98 million +15.8%3.6%3.6 $113.33
3/15/20256,220,000 shares $684.83 million -11.8%3.1%3.3 $110.10
2/28/20257,050,000 shares $735.46 million -0.3%3.6%3.9 $104.32
2/15/20257,070,000 shares $710.67 million -4.7%3.6%4.1 $100.52
1/31/20257,420,000 shares $811.45 million -2.8%3.7%4.4 $109.36
1/15/20257,630,000 shares $811.37 million +4.0%3.8%4.7 $106.34
12/31/20247,340,000 shares $775.32 million +8.4%3.7%4.8 $105.63
12/15/20246,770,000 shares $722.63 million +2.0%3.4%4.5 $106.74
11/30/20246,640,000 shares $744.34 million -3.4%3.3%4.5 $112.10
11/15/20246,870,000 shares $773.15 million +2.7%3.5%4.4 $112.54
10/31/20246,690,000 shares $715.29 million +16.4%3.4%4.6 $106.92
10/15/20245,750,000 shares $601.45 million -14.3%2.8%4 $104.60
9/30/20246,710,000 shares $724.41 million +15.7%3.3%4.5 $107.96
9/15/20245,800,000 shares $616.31 million -1.5%2.9%3.8 $106.26
8/31/20245,890,000 shares $680.06 million +1.7%2.9%3.7 $115.46
8/15/20245,790,000 shares $636.32 million -0.7%2.9%3.8 $109.90
7/31/20245,830,000 shares $649.17 million +0.2%2.9%3.8 $111.35
7/15/20245,820,000 shares $619.95 million +10.2%2.8%3.9 $106.52
6/30/20245,280,000 shares $573.04 million +14.0%2.6%3.6 $108.53
6/15/20244,630,000 shares $496.29 million +1.1%2.3%3.3 $107.19
5/31/20244,580,000 shares $527.39 million -18.9%2.2%3.6 $115.15
5/15/20245,650,000 shares $683.54 million +32.3%2.8%4.6 $120.98
4/30/20244,270,000 shares $513.60 million +0.5%2.1%3.1 $120.28
4/15/20244,250,000 shares $527 million -10.2%2.1%3 $124.00
3/31/20244,730,000 shares $624.27 million +3.1%2.3%3.2 $131.98
3/15/20244,590,000 shares $574.53 million -6.3%2.2%3 $125.17
2/29/20244,900,000 shares $609.36 million +17.5%2.4%2.9 $124.36
2/15/20244,170,000 shares $518.75 million -3.0%N/A2.5 $124.40
1/31/20244,300,000 shares $540.08 million +4.6%N/A2.4 $125.60
1/15/20244,110,000 shares $505.82 million -3.3%N/A2.3 $123.07
12/31/20234,250,000 shares $517.23 million +32.8%N/A2.4 $121.70
12/15/20233,200,000 shares $380.13 million +42.2%N/A1.7 $118.79
11/30/20232,250,000 shares $261.68 million -9.6%N/A1.3 $116.30
11/15/20232,490,000 shares $275.15 million +13.2%N/A1.4 $110.50
10/31/20232,200,000 shares $229.70 million +4.3%N/A1.3 $104.41
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
10/15/20232,110,000 shares $220.07 million -23.0%N/A1.2 $104.30
9/30/20232,740,000 shares $307.48 million +22.9%N/A1.7 $112.22
9/15/20232,230,000 shares $270.52 million +2.8%N/A1.5 $121.31
8/31/20232,170,000 shares $258.49 million -20.2%N/A1.4 $119.12
8/15/20232,720,000 shares $333.17 million -12.5%N/A1.8 $122.49
7/31/20233,110,000 shares $429.65 million -11.7%N/A2.2 $138.15
7/15/20233,520,000 shares $501.14 million -9.5%N/A2.5 $142.37
6/30/20233,890,000 shares $566.11 million +2.1%N/A2.7 $145.53
6/15/20233,810,000 shares $543.23 million +27.0%N/A2.7 $142.58
5/31/20233,000,000 shares $382.02 million +11.9%1.4%2.2 $127.34
5/15/20232,680,000 shares $366.68 million -17.3%1.3%2.2 $136.82
4/30/20233,240,000 shares $448.55 million -6.1%1.6%2.6 $138.44
4/15/20233,450,000 shares $456.68 million +4.9%N/A2.7 $132.37
3/31/20233,290,000 shares $425.07 million -1.8%N/A2.4 $129.20
3/15/20233,350,000 shares $419.62 million +6.0%N/A2.4 $125.26
2/28/20233,160,000 shares $391.43 million +5.0%N/A2.1 $123.87
2/15/20233,010,000 shares $380.80 million +26.5%N/A2.1 $126.51
1/31/20232,380,000 shares $303.07 million +1.7%N/A1.7 $127.34
1/15/20232,340,000 shares $288.71 million -22.3%N/A1.7 $123.38
12/30/20223,010,000 shares $383.78 million -0.3%N/A2.3 $127.50
12/15/20223,020,000 shares $383.60 million +8.2%N/A2.5 $127.02
11/30/20222,790,000 shares $335.08 million +23.5%N/A2.3 $120.10
11/15/20222,260,000 shares $260.17 million -16.6%N/A2 $115.12
10/31/20222,710,000 shares $307.18 million -2.2%N/A2.5 $113.35
10/15/20222,770,000 shares $296.14 million +3.4%N/A2.6 $106.91
9/30/20222,680,000 shares $280.19 million +5.1%N/A2.5 $104.55
9/15/20222,550,000 shares $295.21 million +3.7%N/A2.4 $115.77
8/31/20222,460,000 shares $261.55 million -1.6%N/A2.2 $106.32
8/15/20222,500,000 shares $291.83 million +4.2%N/A2.2 $116.73
7/31/20222,400,000 shares $264.94 million -10.1%N/A2 $110.39
7/15/20222,670,000 shares $276.37 million -0.7%N/A2.1 $103.51
6/30/20222,690,000 shares $282.61 million +4.7%N/A2.1 $105.06
6/15/20222,570,000 shares $274.91 million +19.5%1.3%1.8 $106.97
5/31/20222,150,000 shares $258.45 million -14.3%N/A1.5 $120.21
5/15/20222,510,000 shares $288.83 million -28.5%N/A1.6 $115.07
4/30/20223,510,000 shares $423.83 million +7.0%N/A1.9 $120.75
4/15/20223,280,000 shares $413.28 million -4.4%N/A1.8 $126.00
3/31/20223,430,000 shares $438.70 million +29.9%N/A1.8 $127.90
3/15/20222,640,000 shares $314.69 million +27.5%1.3%1.4 $119.20
2/28/20222,070,000 shares $263.28 million +1.0%1.0%1 $127.19
2/15/20222,050,000 shares $250.39 million -1.0%1.0%1.1 $122.14
1/31/20222,070,000 shares $254.65 million -28.4%1.0%1.1 $123.02
1/15/20222,890,000 shares $368.13 million -3.7%1.4%1.6 $127.38
12/31/20213,000,000 shares $381.12 million +54.6%1.4%1.9 $127.04
12/15/20211,940,000 shares $234.12 million -19.8%0.9%1.3 $120.68
11/30/20212,420,000 shares $289.43 million +18.1%1.2%1.6 $119.60
11/15/20212,050,000 shares $268.82 million -18.7%1.0%1.4 $131.13
10/29/20212,520,000 shares $360.66 million -0.4%N/A1.7 $143.12
10/15/20212,530,000 shares $370.29 million -11.9%N/A1.8 $146.36
9/30/20212,870,000 shares $420.05 million -13.3%N/A1.9 $146.36
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
9/15/20213,310,000 shares $483.29 million +36.8%N/A2.2 $146.01
8/31/20212,420,000 shares $364.09 million -15.1%N/A1.7 $150.45
8/13/20212,850,000 shares $416.36 million +40.4%N/A2 $146.09
7/30/20212,030,000 shares $331.74 million -6.5%N/A1.5 $163.42
7/15/20212,170,000 shares $332.23 million +11.3%1.0%1.8 $153.10
6/30/20211,950,000 shares $313.60 million +4.8%0.9%1.7 $160.82
6/15/20211,860,000 shares $294.51 million -0.5%0.9%1.7 $158.34
5/28/20211,870,000 shares $314.78 million -6.0%0.9%1.8 $168.33
5/14/20211,990,000 shares $329.60 million -12.3%N/A1.9 $165.63
4/30/20212,270,000 shares $405.44 million -9.9%N/A2 $178.61
4/15/20212,520,000 shares $424.14 million -3.1%N/A2.1 $168.31
3/31/20212,600,000 shares $419.17 million +22.1%N/A2.1 $161.22
3/15/20212,130,000 shares $347.53 million -15.1%N/A1.7 $163.16
2/26/20212,510,000 shares $412.90 million -11.0%N/A2 $164.50
2/12/20212,820,000 shares $457.43 million +3.3%N/A2.5 $162.21
1/29/20212,730,000 shares $428.69 million +1.5%N/A2.2 $157.03
1/15/20212,690,000 shares $437.45 million +15.0%N/A2.3 $162.62
12/31/20202,340,000 shares $356.19 million +6.9%N/A2.1 $152.22
12/15/20202,190,000 shares $312.27 million +12.9%N/A2 $142.59
11/30/20201,940,000 shares $291.04 million -4.0%N/A1.8 $150.02
10/30/20202,130,000 shares $285.08 million -16.5%N/A2.1 $133.84
10/15/20202,550,000 shares $371.59 million -15.8%N/A2.6 $145.72
9/30/20203,030,000 shares $412.50 million +9.8%N/A3 $136.14
9/15/20202,760,000 shares $398.27 million -6.4%N/A2.3 $144.30
8/31/20202,950,000 shares $415.60 million -8.1%N/A2.3 $140.88
8/14/20203,210,000 shares $440.80 million +15.5%N/A2.4 $137.32
7/31/20202,780,000 shares $374.91 million +0.4%N/A1.9 $134.86
7/15/20202,770,000 shares $364.86 million -1.1%N/A1.8 $131.72

ZBH Short Interest - Frequently Asked Questions

What is Zimmer Biomet's current short interest?

Short interest is the volume of Zimmer Biomet shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 6,420,000 shares of ZBH short. 3.25% of Zimmer Biomet's shares are currently sold short. Learn More on Zimmer Biomet's current short interest.

What is a good short interest ratio for Zimmer Biomet?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ZBH shares currently have a short interest ratio of 3.0. Learn More on Zimmer Biomet's short interest ratio.

Which institutional investors are shorting Zimmer Biomet?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Zimmer Biomet: Quaker Wealth Management LLC, Jane Street Group LLC, Parallax Volatility Advisers L.P., Millennium Management LLC, BNP Paribas Financial Markets, PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Zimmer Biomet?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.25% of Zimmer Biomet's floating shares are currently sold short.

Is Zimmer Biomet's short interest increasing or decreasing?

Zimmer Biomet saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 6,420,000 shares, an increase of 16.5% from the previous total of 5,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Zimmer Biomet's float size?

Zimmer Biomet currently has issued a total of 197,850,000 shares. Some of Zimmer Biomet's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Zimmer Biomet currently has a public float of 197,580,000 shares.

How does Zimmer Biomet's short interest compare to its competitors?

3.25% of Zimmer Biomet's shares are currently sold short. Here is how the short interest of companies compare to Zimmer Biomet: Penumbra, Inc. (4.10%), Stryker Corporation (1.43%), GE HealthCare Technologies Inc. (1.40%), Koninklijke Philips N.V. (0.32%), Smith & Nephew SNATS, Inc. (0.57%), Solventum Corporation (3.03%), Stevanato Group S.p.A. (4.74%), Glaukos Corporation (7.39%), iRhythm Technologies (8.17%), Inari Medical, Inc. (4.24%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

What does it mean to sell short Zimmer Biomet stock?

Short selling ZBH is an investing strategy that aims to generate trading profit from Zimmer Biomet as its price is falling. ZBH shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Zimmer Biomet?

A short squeeze for Zimmer Biomet occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ZBH, which in turn drives the price of the stock up even further.

How often is Zimmer Biomet's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZBH, twice per month. The most recent reporting period available is June, 15 2025.




This page (NYSE:ZBH) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners